Skip to content
Nextera Lab

Patients Coming Off Anti-Obesity Jabs Regain Pounds Four Times Faster Than People Using Diet and Exercise

Image of pharmaceutical syringe and weighing machine
Weight management involves ongoing approaches.

A recent study indicates that people who come off blockbuster weight-loss injections like semaglutide or tirzepatide may regain reduced body mass at a significantly accelerated pace than those who end traditional diet and exercise programs.

Research printed in a prominent medical journal shows that while overweight individuals can lose about a fifth of their body weight while using the jabs, the weight is regained at an estimated rate of nearly a kilo each month upon discontinuation.

"People purchasing such drugs must be aware of the potential of quick rebound weight gain when the medication ends," stated expert Dr. Susan Jebb.

This pace of regain suggests a return to starting weight in about one and a half years.

Analyzing Therapies

The research, which looked at 37 of studies involving thousands of patients, contrasted the results of the injectable medications with older methods.

Researchers note that individuals who lose weight through lifestyle changes alone usually experience a more gradual creep back—around 100 grams monthly—post-intervention.

Explaining the Fast Rebound

Nutrition scientists believe the mechanism of the drugs accounts for the heightened regain.

These medications copy a natural hormone called GLP-1, which helps regulate hunger.

"Long-term administration of GLP-1 levels several times higher than the body's typical production may cause the system to generate a reduced amount of its own natural hormone, and could lessen responsiveness to its actions," explained Dr. Adam Collins, a nutrition expert.

"Discontinuation of this GLP-1 'fix' results in appetite is unsuppressed, making excessive eating much more probable."

A Lifelong Disease?

Medical guidelines suggest the injections for people with obesity-related medical conditions, alongside prescribed diet and exercise modifications.

A number of clinicians contend that, considering the high risk of weight regain, the treatment should be considered ongoing.

This opinion is supported by drug manufacturers, who state that the results "highlight the long-term character of excess weight," akin to managing conditions like hypertension.

Patient Testimonies

People who have come off the medication report a powerful return of hunger.

"It was like a trigger that goes on and you're instantly ravenous," said a patient.

The struggle is exacerbated if patients have not adopted sustainable lifestyle or habit changes during therapy.

Widespread Interest

Figures indicate that millions of people in the UK have used these injections in the past year, with interest being substantial.

  • Use is greater among women than males.
  • The 40s and 50s demographic shows the greatest level of interest.
  • Many access the drugs through private healthcare rather than public health services.

Finally, experts emphasize that while the jabs are powerful tools for shedding pounds, they are not a magic fix and long-term success hinges on ongoing behavioural management.

About the author

Jorge Adams

A tech enthusiast and digital strategist with a passion for emerging technologies and creative solutions.

Nextera Lab

Type to search articles.